BiotechTube
MZ Biolabs

MZ Biolabs

San Diego, United States· Est.
mzbiolabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MZ Biolabs is a private, early-revenue stage company operating as a specialty testing and discovery services provider. Its core business leverages state-of-the-art mass spectrometry (including HPLC, ESI/APCI sources, and QTOF instruments) to deliver precise analytical data for clients in pharmaceutical, academic, and clinical sectors. The company differentiates itself through deep expertise in custom method development, a DEA license for handling controlled substances, and active internal research into disease biomarkers. With a small, experienced team, MZ Biolabs positions itself as a nimble and responsive partner for complex analytical challenges.

Infectious Disease

Technology Platform

Mass spectrometry-based analytical platform utilizing HPLC, ESI/APCI sources, Linear Ion Trap, and QTOF instruments for targeted metabolomics, proteomics, and custom method development.

Opportunities

Growing demand for outsourced, specialized metabolomics and proteomics data in drug development and biomarker discovery presents a expanding market.
The company's DEA license and custom method development expertise allow it to address high-value, complex analytical challenges that larger labs may avoid, creating a defensible niche.
Internal research on disease signatures could potentially lead to proprietary diagnostic IP.

Risk Factors

Revenue is tied to project-based services, creating vulnerability to downturns in client R&D spending.
The business faces competition from large CROs, academic cores, and other specialty labs, requiring continuous tech investment.
The service model has inherent scalability limits and depends heavily on retaining a small team of key technical experts.

Competitive Landscape

MZ Biolabs competes in the fragmented mass spectrometry services market, which includes large global CROs (e.g., LabCorp, Charles River), university core facilities, and other small specialty labs. Its competitive differentiation lies in its emphasis on custom method development, nimble operations, and DEA licensure, targeting clients with complex, non-standard analytical needs underserved by standardized providers.

More companies in Diagnostics & Precision Medicine →More companies in United States →